Abstract:BACKGROUND & OBJECTIVE:Several researches have reported that epidermal growth factor receptor (EGFR) is expressed frequently in hepatocellular carcinoma (HCC) and paratumor tissues, most likely to contribute to the biological characteristics of HCC, including invasion, metastasis, and resistance to chemotherapy and radiotherapy. The single agent of cetuximab and erlotinib can inhibit the proliferation of HCC cells in vivo and in vitro. This study was to investigate the effects of cetuximab combined erlotinib on the proliferation of HCC cells, and explore the molecular mechanism.METHODS:Increasing concentrations of cetuximab (5-500 mg/mL) and erlotinib (2.5-250 micromol/L) alone or in combination were administrated to HCC cell lines HepG2 and Bel-7402. The inhibitory effects of the drugs on cell proliferation at different time points were observed; the combination index (CI) of these two agents was calculated. The expression of key enzymes in EGFR signaling transduction pathway in HepG2 and Bel-7402 cells after different treatments was detected by Western blot.RESULTS:The single agent of cetuximab and erlotinib inhibited the proliferation of HCC cells in a time-and dose-dependent manner; after 72-hour treatment, the proliferation inhibition rates of HepG2 cells were (43.1+/-1.9)% and (83.4+/-1.3)%, and those of Bel-7402 cells were (35.1+/-2.6)% and (73.9+/-1.2)%. With maximal inhibitory effects of cetuximab combined erlotinib, the proliferation inhibition rates of HepG2 and Bel-7402 cells were (91.1+/-1.0)% and (84.6+/-1.1)%, respectively. The CIs of different concentrations of these two agents at different time points were all less than 1, suggested that they have obvious synergistic activity. The expression of activated key enzymes (p-EGFR, p-ERK1/2, p-AKT) in EGFR signaling transduction pathway in HepG2 and Bel-7402 cells were down-regulated more obviously when these two agents were administrated in combination.CONCLUSIONS:The single agent of cetuximab and erlotinib can inhibit the proliferation of HepG2 and Bel-7402 cells through down-regulating activated key enzymes in EGFR signaling transduction pathway, and they have obvious synergistic activity. The combined EGFR-targeting therapy on HCC xenografts in vivo and on HCC patients is worth of further exploration.

Chrysanthemum Indicum Linné Extracts Attenuate the Mitogenic Effect of Epinephrine on Human HCC Cells

Distinct Effect of Chrysanthemum Indicum Linné Extracts on Isoproterenol-Induced Growth of Human Hepatocellular Carcinoma Cells

Induction of Apoptosis and Cell Cycle Arrest in Human Hcc Mhcc97h Cells with Chrysanthemum Indicum Extract

Effects of Chrysanthemum Indicum Extract on Proliferation and Apoptosis of Human Hepatocellular Carcinoma MHCC97H Cells

Effect of Chinese Gentian on the Proliferation Of, Apoptosis and Phosphorylation of Epidermal Growth Factor Receptor in HaCaT Cells

Chrysanthemum Indicum Ethanolic Extract Inhibits Invasion of Hepatocellular Carcinoma Via Regulation of MMP/TIMP Balance As Therapeutic Target

Stress Hormone Epinephrine Promoting the Growth of Human Hepatocellular Carcinoma Cells Via Β2-Ar-mediated Activation of ERK1/2

The Aryl Hydrocarbon Receptor Ligand ITE Inhibits Cell Proliferation and Migration and Enhances Sensitivity to Drug-Resistance in Hepatocellular Carcinoma.

Inhibiting Effect of Mitomycin C on Human Nasopharyngeal Carcinoma Cell Line HNE2、HNE2/lmp1 and Its Mechanism

Hepatocellular Carcinoma Growth is Inhibited Byeuphorbia Helioscopial. Extract in Nude Mice Xenografts

Actinidia Chinensis Planch Root Extract Attenuates Proliferation and Metastasis of Hepatocellular Carcinoma by Inhibiting Epithelial-Mesenchymal Transition.

Effect of Epiberberine from Coptis Chinensis Franch on Inhibition of Tumor Growth in MKN-45 Xenograft Mice.

Study on Inhibition Effect of Actinidia Chinensis Planch Extracted by Chloroform Proliferation of HEP-2 Cells

Erianin suppresses hepatocellular carcinoma cells through down-regulation of PI3K/AKT, p38 and ERK MAPK signaling pathways.

[Effects of Cetuximab Combined Erlotinib on Proliferation of Human Hepatocellular Carcinoma Cell Lines HepG2 and Bel-7402].

Erianin inhibits the oncogenic properties of hepatocellular carcinoma via inducing DNA damage and aberrant mitosis

[Effect of Tanshinone II A on Expression of EGF and EGFR in Hepatocellular Carcinoma Cell Line SMMC-7721].

Effects of epidermal growth factor receptor antibody on cholangitis

Chrysanthemum Ethanol Extract Induced Loss of Kupffer Cellsviathe Mitochondria-Dependent Apoptotic Pathway

Effect of Ethanol Extracts of Antrodia Cinnamomea on Head and Neck Squamous Cell Carcinoma Cell Line.

Inhibitory Effects of Cepharanthine on Growth and Metastasis of Non-Small Cell Lung Cancer A549 Cells and Gene Expression of Heme Oxygenase-1 and Epidermal Growth Factor Receptor in A549 Cells